231 related articles for article (PubMed ID: 36797628)
1. Secondary Infections in Critical Patients with COVID-19 Associated ARDS in the ICU: Frequency, Microbiologic Characteristics and Risk Factors.
Taysi MR; Yildirim F; Simsek M; Dural HI; Sencan I
J Coll Physicians Surg Pak; 2023 Feb; 33(2):181-187. PubMed ID: 36797628
[TBL] [Abstract][Full Text] [Related]
2. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.
Ripa M; Galli L; Poli A; Oltolini C; Spagnuolo V; Mastrangelo A; Muccini C; Monti G; De Luca G; Landoni G; Dagna L; Clementi M; Rovere Querini P; Ciceri F; Tresoldi M; Lazzarin A; Zangrillo A; Scarpellini P; Castagna A;
Clin Microbiol Infect; 2021 Mar; 27(3):451-457. PubMed ID: 33223114
[TBL] [Abstract][Full Text] [Related]
3. Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study.
Pandey M; May A; Tan L; Hughes H; Jones JP; Harrison W; Bradburn S; Tyrrel S; Muthuswamy B; Berry N; Pugh R; Sutton D; Campbell A; Morgan M
Crit Care; 2022 Jun; 26(1):158. PubMed ID: 35655224
[TBL] [Abstract][Full Text] [Related]
4. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R;
JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
[TBL] [Abstract][Full Text] [Related]
7. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
[TBL] [Abstract][Full Text] [Related]
8. Secondary infections in a cohort of patients with COVID-19 admitted to an intensive care unit: impact of gram-negative bacterial resistance.
Costa RLD; Lamas CDC; Simvoulidis LFN; Espanha CA; Moreira LPM; Bonancim RAB; Weber JVLA; Ramos MRF; Silva ECF; Oliveira LP
Rev Inst Med Trop Sao Paulo; 2022; 64():e6. PubMed ID: 35137900
[TBL] [Abstract][Full Text] [Related]
9. Bloodstream and respiratory coinfections in patients with COVID-19 on ECMO.
Shih E; Michael DiMaio J; Squiers JJ; Banwait JK; Kussman HM; Meyers DP; Meidan TG; Sheasby J; George TJ
J Card Surg; 2022 Nov; 37(11):3609-3618. PubMed ID: 36073136
[TBL] [Abstract][Full Text] [Related]
10. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
11. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
12. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
Guven BB; Erturk T; Kompe Ö; Ersoy A
Epidemiol Infect; 2021 Jun; 149():e137. PubMed ID: 34099076
[TBL] [Abstract][Full Text] [Related]
13. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation.
De Bruyn A; Verellen S; Bruckers L; Geebelen L; Callebaut I; De Pauw I; Stessel B; Dubois J
BMC Infect Dis; 2022 Mar; 22(1):207. PubMed ID: 35236299
[TBL] [Abstract][Full Text] [Related]
14. Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital.
Tian H; Chen L; Wu X; Li F; Ma Y; Cai Y; Song S
Dig Dis Sci; 2020 Jul; 65(7):2079-2088. PubMed ID: 31691173
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. Nucleated red blood cells are a late biomarker in predicting intensive care unit mortality in patients with COVID-19 acute respiratory distress syndrome: an observational cohort study.
Schmidt G; Martens A; Koch C; Markmann M; Schneck E; Matt U; Hecker M; Tello K; Wolff M; Sander M; Vadász I
Front Immunol; 2024; 15():1313977. PubMed ID: 38304431
[TBL] [Abstract][Full Text] [Related]
17. Delirium in Adults With COVID-19-Related Acute Respiratory Distress Syndrome: Comparison With Other Etiologies.
Bernard-Valnet R; Favre E; Bernini A; Oddo M; Chiche JD; Du Pasquier RA; Rossetti AO;
Neurology; 2022 Nov; 99(20):e2326-e2335. PubMed ID: 36376086
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Risk Factors, and Prognosis of Bloodstream Infections in COVID-19 Patients in Intensive Care: A Single-Center Observational Study.
Kurt AF; Mete B; Urkmez S; Demirkiran O; Dumanli GY; Bozbay S; Dilken O; Karaali R; Balkan II; Saltoğlu N; Dikmen Y; Tabak F; Aygun G
J Intensive Care Med; 2022 Oct; 37(10):1353-1362. PubMed ID: 35607286
[TBL] [Abstract][Full Text] [Related]
19. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.
Mahida RY; Chotalia M; Alderman J; Patel C; Hayden A; Desai R; Beesley E; Crowley LE; Soltan M; Bangash M; Parekh D; Patel J; Thickett DR
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33257441
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
